306 filings
424B3
BTTX
Better Therapeutics Inc
21 Mar 24
Prospectus supplement
4:03pm
8-K
BTTX
Better Therapeutics Inc
21 Mar 24
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
4:01pm
424B3
BTTX
Better Therapeutics Inc
15 Mar 24
Prospectus supplement
9:39am
8-K
BTTX
Better Therapeutics Inc
15 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:33am
424B3
BTTX
Better Therapeutics Inc
14 Mar 24
Prospectus supplement
9:37am
8-K
4r2ic4vjsdl2nrm6knjv
14 Mar 24
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
9:35am
8-K
fh49yic7p
11 Mar 24
Regulation FD Disclosure
9:01am
8-K
2a7yx2atp sef
4 Mar 24
Regulation FD Disclosure
8:51am
RW
721tgl4xa2n8lr
1 Mar 24
Registration withdrawal request
6:08am
4
xpn7le5cttcl58cu
13 Feb 24
Better Therapeutics / DAVID P PERRY ownership change
9:50pm
SC 13G/A
aa4p3q
13 Feb 24
Better Therapeutics / MMCAP International Inc. SPC ownership change
1:00pm
SC 13D/A
agcdkc
12 Feb 24
Better Therapeutics / David P. Perry 2015 Trust ownership change
4:28pm
SC 13D/A
9kkc7
25 Jan 24
Better Therapeutics / David P. Perry 2015 Trust ownership change
4:30pm
D
kzzsusxu7m5hwe06b
23 Jan 24
$250.00 k in equity, sold $250.00 k, 1 investor
5:22pm
4
unmq6yzy b3pq13d
10 Jan 24
Better Therapeutics / DAVID P PERRY ownership change
4:19pm
424B3
gk4j4fb
10 Jan 24
Prospectus supplement
7:01am
8-K
40sque2oq3m
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
424B3
uptw lp81
28 Dec 23
Prospectus supplement
9:23pm
EFFECT
wit3ds n27wd
28 Dec 23
Notice of effectiveness
12:15am